Compare BioNano Genomics Inc (BNGO) vs United Airlines Holdings Inc (UAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs United Airlines Holdings Inc — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.66M), while United Airlines Holdings Inc trades at $125.25 (market cap $41.00B). The key difference: United Airlines Holdings Inc is far larger — about 3001.5× BioNano Genomics Inc's market cap, and United Airlines Holdings Inc is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | UAL | |
|---|---|---|
Market Cap | $13.66M | $41.00B |
Sector | Health | Industrials |
52-Week High | $4.92 | $136.11 |
52-Week Low | $1.06 | $85.21 |
Enterprise Value | $16.26M | $58.03B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.195, up 3.02% today, with a bullish technical signal from moving averages but a neutral oscillator stance. The company shows improving financial trends, with net losses narrowing to -$26.40M in 2025 from -$232M in 2023, and recent earnings beats. Revenue stabilized around $29M, while cash flow trends indicate reduced operational cash burn. Analyst sentiment is positive, with 57% buy ratings.
The outlook for BNGO hinges on sustaining revenue growth and achieving profitability, supported by strategic hires and debt retirement. Key risks include persistent negative margins and high cash burn. With a low P/S of 0.31, the stock offers value if execution improves, but investors face volatility from operational challenges and competitive pressures.
United Airlines (UAL) trades at $125.37, up 1.3% today, with a bullish technical signal from moving averages. The stock shows strong fundamentals with a low P/E of 11.83 and robust ROE of 23.25%. Recent earnings have consistently beaten estimates, and revenue is projected to grow to $62.9B in 2026. Analyst sentiment is overwhelmingly positive with a $167.73 consensus price target and no sell ratings.
The outlook for UAL is favorable due to solid earnings momentum and improving debt metrics, though risks include fuel cost volatility and execution of fleet innovation. The stock presents a value opportunity with upside potential, supported by strong institutional buy-in and manageable liabilities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About United Airlines Holdings Inc
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →
